comparemela.com

Latest Breaking News On - Soliton inc - Page 7 : comparemela.com

SOLITON ALERT: Bragar Eagel & Squire, P C Investigates Sale of SOLY and Encourages Investors to Contact the Firm

SOLITON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SOLY and Encourages Investors to Contact the Firm NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Soliton, Inc. (NASDAQ: SOLY) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by AbbVie, Inc. (NYSE: ABBV). Click here to learn more and participate in the action. On May 10, 2021, Soliton announced that it had signed an agreement to be acquired by AbbVie for approximately $550 million. Pursuant to the merger agreement, Soliton stockholders will receive $22.60 in cash for each share of Soliton common stock owned.

Mid-day market update: Nasdaq drops 200 points; Soliton shares spike higher

5/10/2021 4:47:25 PM GMT Midway through trading Monday, the Dow traded up 0.86% to 35,078.24 while the NASDAQ fell 1.5% to 13,546.64. The S&P also rose, gaining 0.01% to 4,233.22. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,708,020 cases with around 581,750 deaths. India confirmed a total of at least 22,662,570 cases and 246,110 deaths, while Brazil reported over 15,184,790 COVID-19 cases with 422,340 deaths. In total, there were at least 158,399,250 cases of COVID-19 worldwide with more than 3,294,610 deaths, according to data compiled by Johns Hopkins University. Leading and Lagging Sectors Consumer staples shares rose 1.4% on Monday. Meanwhile, top gainers in the sector included 22nd Century Group, Inc. XXII 5.28%, up 5%, and BellRing Brands, Inc. BRBR 5.63%, up 4%.

SHAREHOLDER ALERT: Rigrodsky Law, P A Announces Investigation of Soliton, Inc Buyout

Press release content from Globe Newswire. The AP news staff was not involved in its creation. SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Soliton, Inc. Buyout Rigrodsky Law, P.AMay 10, 2021 GMT WILMINGTON, Del., May 10, 2021 (GLOBE NEWSWIRE) Rigrodsky Law, P.A. announces that it is investigating Soliton, Inc. (“Soliton”) (NASDAQ GS: SOLY ) regarding possible breaches of fiduciary duties and other violations of law related to Soliton’s agreement to be acquired by AbbVie Inc. (“AbbVie”) (NYSE: ABBV ).   Under the terms of the agreement, Soliton’s shareholders will receive $22.60 in cash per share. ADVERTISEMENT To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-soliton-inc.

(SOLY), (ABBV) - Soliton Stock Rallies After $22 60/Share Buyout From AbbVie

(SOLY), (ABBV) - Soliton Stock Rallies After $22 60/Share Buyout From AbbVie
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Soliton, Inc

WeissLaw LLP is investigating whether (i) Soliton s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the merger consideration adequately compensates Soliton s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. Notably, the merger consideration is $2.40 below the $25 median price target set by analysts covering the Company and $7.40 below the high price target of $30. WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information),

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.